Slide 1 Antibiotics and Risk of New Onset Inflammatory Bowel Disease: A Meta-Analysis Ryan Ungaro 1, Charles Bernstein 2, Richard Gearry 3, Anders Hviid 4, Kaija-Leena Kolho…
Slide 1 Inflammatory Bowel Disease A Aljebreen FRCPC Slide 2 Introduction IBD characterized by a tendency for chronic or relapsing immune activation and inflammation within…
Antibiotics and Risk of New Onset Inflammatory Bowel Disease: A Meta-Analysis Antibiotics and Risk of New Onset Inflammatory Bowel Disease: A Meta-Analysis Ryan Ungaro1,…